Sign in

NCT07825636Completed

Sensorimotor Function in COPD

Sensorimotor Function Impairment in Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 17 Sept 2026

Brief summary (registry, in English)

The aim of this study was to investigate the level of sensorimotor function impairment according to disease stage in individuals with Chronic Obstructive Pulmonary Disease (COPD) and to determine whether functional differences exist between individuals with COPD and healthy controls.

Status (registry)
Completed
Study type
Observational
Enrollment
95 (actual)
First submitted
6 Sept 2026
Start date
1 Oct 2024
Primary completion date
1 May 2026
Lead sponsor
Alanya Alaaddin Keykubat University
Diseases
COPD
NCT number
NCT07825636

What you commit to

  • Study type: Observational
  • Participants enrolled: 95
  • From 1 Oct 2024 to the primary completion date, 1 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with uncorrected visual and hearing impairment,
  • Individuals with a diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.).
  • Individuals with uncorrected visual and hearing impairment,
  • A diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.) will be excluded from the study.

Who the study is looking for

  • Individuals diagnosed with COPD,
  • Aged 40-65 years, who volunteer to participate in the study,
  • Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems, or respiratory failure (not using long-term home oxygen therapy or non-invasive mechanical ventilation) will be included.
  • Individuals aged 40-65 years who volunteer to participate in the study,
  • Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems,
  • Who do not have communication problems will be included.

Age in the registry: 40 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alanya Alaaddin Keykubet University
Coordinator of this site? Confirm its status
AntalyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.